TrialWorld journal of urology2022

Survival with novel hormonal therapies in patients with nonmetastatic castration-resistant prostate cancer: indirect comparison of three randomized phase-III trials.

Melania Rivano et al.PubMed ↗Publisher ↗

No numbers read from the abstract.